semaglutide vs retatrutide What Is Retatrutide? Side Effects, Dosing, & Weight Loss Retatrutide vs semaglutide research

Retatrutide appears to have more average weight loss (24.2%) vs

Adverse Effects : Adverse effects related to the use of GLP-1 receptor agonist drugs can also act as a restraining factor

Use of XIGDUO XR for this indication is supported by a 26week placebo-controlled trial of dapagliflozin with a 26week extension in 157 pediatric patients aged 10 to 17 years with type 2 diabetes mellitus, pediatric pharmacokinetic data, and trials in adults with type 2 diabetes mellitus [see Clinical Pharmacology (12.3) and Clinical Studies (14.1, 14.2)]

Any website, clinic, or individual claiming to sell retatrutide is supplying an unlicensed and unauthorised medicine, which may be illegal and potentially unsafe